Wide Ranks

CLPT

ClearPoint Neuro Inc.

12.11

Top Statistics
Market Cap 334 M Forward PE -20.76 Revenue Growth 41.00 %
Current Ratio 4.54 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins -59.64 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -17.64 Enterprise / Revenue 10.39 Price To Sales Trailing12 Months 10.98
Profitability
Profit Margins -59.64 % Operating Margins -63.68 %
Balance Sheet
Total Cash 21 M Total Cash Per Share 0.7820 Total Debt 3 M
Total Debt To Equity 12.74 Current Ratio 4.54 Book Value Per Share 1.05
All Measures
Short Ratio 277.00 % Message Board Id finmb_1432648 Shares Short Prior Month 712158
Return On Equity -0.6836 City Solana Beach Uuid 71a1dc2f-d47a-37fe-a48e-e2b464988296
Previous Close 11.96 First Trade Date Epoch Utc 1 B Book Value 1.05
Beta 1.11 Total Debt 3 M Volume 114312
Price To Book 11.52 Last Split Date 1 B Fifty Two Week Low 5.11
Total Cash Per Share 0.7820 Total Revenue 30 M Shares Short Previous Month Date 1 B
Target Median Price 17.00 Max Age 86400 Recommendation Mean 1.00
Sand P52 Week Change 0.3133 Operating Margins -63.68 % Target Mean Price 16.33
Net Income To Common -18147000 Short Percent Of Float 0.0283 Implied Shares Outstanding 27 M
Trailing Peg Ratio None Last Fiscal Year End 1 B Average Daily Volume10 Day 201320
Average Volume10days 201320 Total Cash 21 M Next Fiscal Year End 1 B
Revenue Per Share 1.16 Held Percent Insiders 0.0783 Ebitda Margins -58.91 %
Trailing PE 0.0000 Date Short Interest 1 B Most Recent Quarter 1 B
Regular Market Previous Close 11.96 Target Low Price 15.00 Gmt Off Set Milliseconds -18000000
Fifty Day Average 11.90 Open 11.96 Free Cashflow -1287000
State CA Dividend Yield 0.00 % Return On Assets -0.2804
Time Zone Short Name EST Trailing Eps -0.6900 Day Low 11.86
Address1 120 S. Sierra Avenue Shares Outstanding 27 M Price Hint 2
Target High Price 17.00 Website https://www.clearpointneuro.com 52 Week Change 1.10
Average Volume 205318 Forward Eps -0.6100 Recommendation Key strong_buy
Compensation As Of Epoch Date 1 B Quick Ratio 345.60 % Last Split Factor 1:40
Regular Market Day High 12.19 Is_sp_500 False Profit Margins -59.64 %
Debt To Equity 12.74 Fifty Two Week High 14.13 Day High 12.19
Shares Short 759900 Regular Market Open 11.96 Industry Key medical-devices
Earnings Growth 0.00 % Enterprise To Revenue 10.39 Revenue Growth 41.00 %
Shares Percent Shares Out 0.0275 Operating Cashflow -8876000 Currency USD
Time Zone Full Name America/New_York Market Cap 334 M Is_nasdaq_100 False
Zip 92075 Quote Type EQUITY Industry Medical Devices
Long Name ClearPoint Neuro, Inc. Regular Market Day Low 11.86 Held Percent Institutions 0.3054
Current Price 12.11 Address2 Suite 100 Enterprise To Ebitda -17.64
Financial Currency USD Current Ratio 4.54 Gross Margins 60.38 %
Industry Disp Medical Devices Number Of Analyst Opinions 3 Country United States
Float Shares 25 M Two Hundred Day Average 8.47 Enterprise Value 316 M
Price To Sales Trailing12 Months 10.98 Forward PE -20.76 Regular Market Volume 114312
Ebitda -17925000 Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha 
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States.

It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions.

The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain.

It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.

V.

, UCB Biopharma SRL, and University of California and San Francisco; and development and license agreement with NE Scientific, LLC.

The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020.

ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.